Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-06-059664
Filing Date
2006-10-25
Accepted
2006-10-25 19:04:36
Documents
1
Period of Report
2006-10-25

Document Format Files

Seq Description Document Type Size
1 GILEAD FORM 3 10-25-06 rrd133754.html 3  
1 GILEAD FORM 3 10-25-06 rrd133754.xml 3 4533
  Complete submission text file 0001181431-06-059664.txt   6413
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Reporting) CIK: 0000882095 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 061163959
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 1003 WEST SEVENTH ST SUITE 401 FREDERICK MD 21701 3016968889
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations